NPRL2 Polyclonal Antibody, 20ul Monoclonal Antibody Preparation perfect for challenging experiments

perfect for challenging experiments

The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum

suggesting its involvement in the TP53-dependent regulatory pathway

translocates into the nucleus

EphA3 (Hek4)

NPRL2 Polyclonal Antibody, 20ul Monoclonal Antibody Preparation perfect for challenging experimentsSuppresses Src dependent tyrosine phosphorylation and activation of PDPK1 and its downstream signaling. Down regulates PDPK1 kinase activity by interfering with tyrosine phosphorylation at the Tyr 9 Tyr 373 and Tyr 376 residues. May act as a tumor suppressor. Suppresses cell growth and enhanced sensitivity to various anticancer drugs.